FORT LEE, N.J., Feb. 14,
2013 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM)
www.herborium.com, a Botanical Therapeutics® Company
has announced today that it has completed the manufacturing
of its unique, all herbal Sexual Enhancement Products
Lasting Pleasure® for women and Lasting Power® for
men. After the products are packaged using a very attractive and
unique, environmentally sustainable European package design they
are both expected to hit the market in March
2013.
Lasting Pleasure® and Lasting Power® represent
over $1.5 billion market potential
for natural sexual health products and has already been
featured in November 2012,
USA Today, Sexual Health Issue:
"Healthy Relationships."
In addition, there is a growing need for women's sexual health
products. The female sexual enhancement industry is poised for an
explosion and is expected to grow into a multibillion dollar
business as women themselves become increasingly aware of their
sexuality and their sexual health. In 2012 the sales of female
personal lubricants grew 41%. There is no Viagra comparative
product on the market for women and Herborium's Lasting
Pleasure® for Women is the ONLY product of its kind.
"We are extremely excited to be preparing an immediate roll-out
of our sexual health products and we cannot find a better day to
announce it - than a Valentine's
Day." Commented Dr. Agnes
P. Olszewski, Chairwoman & CEO of Herborium.
"Herborium's sexual enhancement products' trajectory is for long
term growth and it is also supported by its association with
Kamasutra™ Spirit of Seduction – an innovative adult beverage
developed with an unique herbal formula invented by Herborium.
Kamasutra™ social media
presence, www.kamasutraspirit.com and each bottle of
Kamasutra™ product include references to Herborium's sexual
health products. This represents a measurable value and most
advantageous marketing opportunities for Lasting Pleasure®
and Lasting Power®," concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company
sells its products in the US and Europe. For more information, please visit
www.herborium.com, www.herboriumsh.com, and www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.